exposures, including smoking, viral infections, early-life adversity, pollution, and others.
current cellular state and gene expression
health trajectories and cell fate
Measure: quantifiable markers of disease risk and ageing.
Modify: leverage epigenome to modulate health trajectories and cell fates.
Unlocking the epigenetic code
Our research investigates how the epigenome encodes biological experiences, how this encoding shapes stem cell function across tissues, and whether these mechanisms can be measured non-invasively and causally modulated to influence ageing and disease trajectories.
Defining how DNA methylation encodes biological experience across tissues and stem cells.
Translating epigenetic memory into non-invasive biomarkers that capture vulnerability, resilience, and disease risk before clinical onset.
Using experimental systems to test whether epigenetic states causally influence stem cell behaviour and ageing.
Pushing the boundaries of geroscience
Leading research in epigenetics to transform how we understand and modulate ageing.
Peter Brederlow is a visiting MSc student from the University of Tübingen, studying Bioinformatics
Jan-Mar 2026. Jordan was an undergraduate student working on large-scale data harmonisation and improvement of computational tools for ageing research.
Stay connected with our research through talks, workshops, and other events.
Dr. Chiara Herzog presents a seminar titled "What the epigenome remembers - past, present, and future" at the Stanford Institute for Immunity, Transplantation and Infection Speaker …
Dr. Chiara Herzog vice-chairs the 2026 Biomarkers of Aging Conference at Harvard Medical School.
Dr. Chiara Herzog joins the 2026 GRC Systems Aging Conference in Newry, Maine.
Herzog Lab
Cambridge Stem Cell Institute
Jeffrey Cheah Biomedical Centre
Puddicombe Way
Cambridge Biomedical Campus
CB2 0AW, Cambridge
United Kingdom
